← Insider buys
NTLA

Intellia Therapeutics, Inc. · Healthcare

President and CEO John M Leonard sold $3.7M of Intellia Therapeutics, Inc.

Sold$3,655,410
$71.70Price
50,985Shares
−7%Stake

What NTLA did after the filing

Prices for NTLA after this filing aren't in yet.

Traded Fri, Feb 5. Filed Tue, Feb 9, 8:36 PM ET, after the close. Not investment advice.